ahlam1399
03-10-2016, 12:51 AM
Exclusive: Teva set to win EU okay for $40.5 billion Allergan deal ? sources
BRUSSELS (Reuters) - Teva Pharmaceutical Industries is expected to win EU antitrust approval for its $40.5 billion bid for Allergan's generics unit after agreeing to sell off some of its products to appease regulators, three people familiar with the matter said on Wednesday.
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654199/s/4e2620ec/sc/24/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/businessNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/businessNews?a=al1StxELSa0:5DxQ42f1pMw:yIl2AUoC8zA ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=al1StxELSa0:5DxQ42f1pMw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/businessNews?a=al1StxELSa0:5DxQ42f1pMw:F7zBnMyn0Lo ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=al1StxELSa0:5DxQ42f1pMw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/businessNews?a=al1StxELSa0:5DxQ42f1pMw:V_sGLiPBpWU )
http://feeds.feedburner.com/~r/reuters/businessNews/~4/al1StxELSa0
BRUSSELS (Reuters) - Teva Pharmaceutical Industries is expected to win EU antitrust approval for its $40.5 billion bid for Allergan's generics unit after agreeing to sell off some of its products to appease regulators, three people familiar with the matter said on Wednesday.
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654199/s/4e2620ec/sc/24/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/businessNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/businessNews?a=al1StxELSa0:5DxQ42f1pMw:yIl2AUoC8zA ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=al1StxELSa0:5DxQ42f1pMw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/businessNews?a=al1StxELSa0:5DxQ42f1pMw:F7zBnMyn0Lo ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=al1StxELSa0:5DxQ42f1pMw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/businessNews?a=al1StxELSa0:5DxQ42f1pMw:V_sGLiPBpWU )
http://feeds.feedburner.com/~r/reuters/businessNews/~4/al1StxELSa0